Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Revenue Recognition - tebdrew

May 02, 2008 07:35PM

May 02, 2008 10:13PM
10
May 02, 2008 10:36PM
1
May 02, 2008 10:57PM

May 02, 2008 11:06PM
3
May 02, 2008 11:28PM
2
May 03, 2008 03:28AM
1
May 03, 2008 08:13AM
4
May 03, 2008 08:26AM
2
May 03, 2008 08:51AM

Revenue from technology license agreements is recognized at the time we enter into a contract and provide the customer with the licensed technology. At this point, we have performed all of our obligations under contract, the rights to our technology have been transferred and no significant performance obligations remain.

I should have included the complete 10Q statement (above) with my last posting. It helps make my point:

There may still be room for other qualifiers that might defer recognition of revenue.

Was the customer "provided with the licensed technology" as of Q period end? Or, were there other TPL/PTSC agreement obligations that were not yet fulfilled by Q period end?

2
May 03, 2008 09:02AM
Share
New Message
Please login to post a reply